搜尋結果
Innovent’s Obesity Drug Shows Similar Weight Loss as Eli Lilly’s
Bloomberg· 1 日前Have a confidential tip for our reporters? A new obesity drug co-developed by China’s Innovent ...
Novo Nordisk’s Wegovy Weight-Loss Drug Gets Approval in China
The Wall Street Journal· 1 日前Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo ...
Novo Nordisk’s Wegovy Approved in China for Weight Loss
Bloomberg· 1 日前China has approved Novo Nordisk A/S’s blockbuster Wegovy for chronic weight management, opening up competition ...
Novo Nordisk's Wegovy weight loss drug approved in China
CNBC· 2 日前Novo Nordisk said Tuesday that its Wegovy weight loss treatment has been approved in China for ...
Hong Kong Book Fair eyes more visitors from Greater Bay Area
South China Morning Post· 2 日前“We will play a part in it because we have already been listed as one of the mega events in the ...
AstraZeneca's Imfinzi fails in late-stage trial to treat certain type of lung cancer
Reuters· 2 日前AstraZeneca said on Tuesday its blockbuster cancer drug, Imfinzi, failed to improve disease-free survival ...
Shock ETF Data Reveals Bitcoin Is Braced For A ‘True Correction’ After $300 Billion Crypto ...
Forbes· 2 日前... to Forbes' CryptoAsset & Blockchain Advisor and "uncover blockchain blockbusters ...
Disney Continues To Have The Largest Audience Of Any Media Company
Forbes· 2 日前Nielsen released their second monthly Media Distribution Gauge Report which finds Disney ...
Will Elevidys Approval Make Sarepta Stock An Acquisition Target?
Forbes· 2 日前The stock price of Sarepta Therapeutics, a biotech company focused on the discovery and development of RNA-targeted therapeutics ...
‘Jaws @ 50’ Documentary Greenlit By Nat Geo; 5 ‘Jaws’ Factoids To Whet Your Appetite
Forbes· 2 日前"Jaws @ 50" will focus on Steven Spielberg’s movie and the bestselling novel by Peter ...